New York bill to ban flavored nicotine pouches withdrawn temporarily

Apr.18
New York bill to ban flavored nicotine pouches withdrawn temporarily
New York proposed bill to ban flavored nicotine pouches, including ZYN, to prevent youth appeal, facing industry resistance.

Key Points:

Legislation: A bill under consideration in the state of New York in the United States is proposing to ban most flavored nicotine pouches, except for mint, due to concerns that they may attract minors.

Legislative process: The bill has been included in the agenda of the state legislature's Health Committee, but was withdrawn by the chairman before the vote.

Reason for withdrawal: The FDA just approved some ZYN products, and the committee wants to give the company time to make compliance adjustments. Members believe that some absences of legislators and strong lobbying from the industry led to the withdrawal.

Opposing forces: Philip Morris International (PMI) (ZYN), Swisher (Rogue), RAI Services (Velo), and the convenience store association all expressed opposition, stating that the "ban is ineffective".

Policy outlook: Legislators have indicated that they will reintroduce the bill during the current legislative session, which runs until mid-June.


According to a report by Gothamist on April 17th, a bill in the state of New York aimed at banning flavored nicotine pouches (such as ZYN) has been withdrawn due to strong lobbying efforts by the tobacco industry and regulatory coordination issues, temporarily halting the legislative process.

 

The bill was introduced by Democratic State Assemblywoman Linda Rosenthal and State Senator Brad Hoylman-Sigal from Manhattan, New York. It aims to ban all flavored nicotine pouch products except mint, such as "coffee" or "citrus" flavors, due to concerns that these products may appeal to minors. Unscented products would still be allowed for sale.

 

Last week, the bill made its way onto the agenda of the state legislative health committee, a key signal that it was moving closer to being considered by the full legislature. However, just before the vote, committee chair Amy Paulin removed the bill from the agenda.

 

The official explanation provided by Paulin is that the U.S. FDA recently approved the launch of some ZYN products, but companies are still prohibited from marketing to minors. As a result, the committee has decided to give companies time to make compliance adjustments and will not take action at the state level for the time being.

 

Rosenthal also pointed out that two key factors contributed to the dismissal of the case:

 

Firstly, some committee members were absent that day, impacting voting arrangements. Secondly, lobbying pressure from tobacco companies, convenience store industry, and business groups has significantly increased. Organizations opposing the bill include companies such as Philip Morris International (PMI), Swisher International (Rogue), RAI Services (Velo), and the New York State Association of Convenience Stores, representing 1,600 stores statewide.

 

The president of the association, Alison Ritchie, stated, "The ban is unworkable, and New York should know best. The lawmakers pushing for this ban have become disconnected from the everyday lives of New Yorkers.

 

Although the process was stalled this time, Rosenthal said he still plans to push the bill again during this legislative session (until mid-June). Previous smoking bans in New York City have been effective: according to the city's health department, the smoking rate among adults in New York City was 22% in 2003 and has since decreased to 8% by 2023.

Notice

1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.

2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.

3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.

Copyright

This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.

This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.